US 11324820
Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
granted A61KA61K2039/5256A61K2039/545
Quick answer
US patent 11324820 (Methods for the treatment of subjects having a hepatitis b virus (HBV) infection) held by Alnylam Pharmaceuticals, Inc. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/5256, A61K2039/545, A61K2039/55555, A61K2039/55561